glp 1 agonist vs sglt2 inhibitor inhibitors or GLP-1 receptor agonists as second-line therapy in | VHRM Benefits of treatment with SGLT2i

Endocr J

Smaller pediatric studies have also noted improvements in insulin sensitivity (e.g., lower fasting insulin or HOMA-IR) and even blood pressure with GLP-1 RAinduced weight loss

Some investigators have proposed that GLP-1RAs improve myocardial insulin sensitivity, enhance glucose oxidation rates, reduce fatty acid oxidation, and thereby optimize myocardial energy metabolism, ultimately improving cardiac function.106 In a randomized controlled trial (RCT) conducted by Mikhail et al,106 semaglutide efficacy was evaluated in 616 patients with obesity-related heart failure and T2DM

Consumption of olive oil and risk of total and cause-specific mortality among U.S